AMG National Trust Bank Raises Holdings in CVS Health Co. (NYSE:CVS)

AMG National Trust Bank boosted its stake in CVS Health Co. (NYSE:CVS - Free Report) by 123.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,975 shares of the pharmacy operator's stock after purchasing an additional 62,861 shares during the period. AMG National Trust Bank's holdings in CVS Health were worth $7,167,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health during the third quarter valued at approximately $32,000. First Community Trust NA increased its stake in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after buying an additional 302 shares during the period. Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health during the third quarter valued at approximately $33,000. Finally, ORG Partners LLC increased its stake in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator's stock valued at $35,000 after buying an additional 592 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 5.4 %

CVS stock traded up $2.89 on Monday, hitting $56.08. 18,702,738 shares of the company's stock were exchanged, compared to its average volume of 11,374,905. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The firm has a 50 day moving average price of $59.19 and a two-hundred day moving average price of $58.60. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market cap of $70.57 billion, a P/E ratio of 14.23, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.21 EPS. As a group, equities research analysts expect that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.74%. CVS Health's payout ratio is presently 67.51%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday. UBS Group lifted their price target on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. TD Cowen upgraded CVS Health from a "hold" rating to a "buy" rating and lifted their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Royal Bank of Canada dropped their price target on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research report on Friday. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $72.78.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.